Grants for Public and State controlled institutions of higher education - Federal

The Centers of Research Excellence in Science and Technology (CREST) program provides support toenhance the research capabilities of minority-serving institutions (MSI) through the establishment of centersthat effectively integrate education and research. CREST promotes the development of new knowledge,enhancements of the research productivity of individual faculty, and an expanded presence of studentsunderrepresented in science, technology, engineering, and mathematics (STEM) disciplines. The HBCU-RISE is a component of the CREST program that supports the expansion of institutional research capacity as well as the successful training of doctoral students, especially those from groups underrepresented in STEM at HBCUs. HBCU-RISE projects must have a unifying research focus in one of the research areas supported by NSF; a direct connection to the long-term plans of the host department(s) and the institutions strategic plan and mission; and plans for expanding institutional research capacity as well as increasing the production of doctoral students, especially those underrepresented in STEM.

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

This funding opportunity supports projects that develop and operate geologic field laboratories for carbon storage technology, targeting organizations with access to suitable sites for testing and advancing carbon capture solutions.

The overarching goals of this study are 1) to update oil spill rates of OCS platforms, OCS pipelines, and U.S. barges, 2) to obtain oil spill information for BOEMs Offshore Environmental Cost Model (OECM), 3) to analyze oil spill trend and casual factors. Having updated oil spill and oil spill occurrence rate data is critically important to analyze the potential risk and consequence of OCS oil spills, investigate causal factors contributing to the occurrence, size or frequency of oil spills, enhance oil-spill response planning, and target future regulatory reform to better manage risk.Specific objectives are:Compilation of oil spill data and QA/QC of the dataExamination of historical spill occurrences and of volume of oil handledAnalysis of other potential exposure variablesEstimate spill occurrence rates and normalize these rates based on number of spills per volume handled and other potential exposure variablesAnalyses on oil spill trend and casual factorsProvide information for OECM modelPrepare a 508 compliant report according to BOEMs specifications.

The United States Department of Agricultures (USDA) Animal and Plant Health Inspection Service (APHIS) Veterinary Services (VS) is announcing the availability of cooperative agreement funding to carry out the Antimicrobial Resistance Dashboard (AMR Dashboard) as described in the U.S. House of Representatives Report for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill, 2021. Through public-private partnerships, USDA APHIS will develop and utilize antimicrobial resistance dashboard tools to improve access to information on antimicrobial resistance in domesticated animals, including livestock, poultry, and companion animals. All antimicrobial resistance dashboard tools developed will provide data protections similar to the Confidential Information Protection and Statistical Efficiency Act. Once created, the antimicrobial resistance dashboard tools will be used to monitor trends in antimicrobial resistance patterns, detect emerging resistance profiles, and better understand relationships between antimicrobial use and animal health management practices and antimicrobial resistance. Additional details about the program and this funding opportunity, including additional information for applicants, are available at USDA APHIS One Health Funding Opportunities.

This funding opportunity supports U.S.-based institutions conducting open-source scientific research to promote transparency and collaboration in space and Earth sciences.

This funding opportunity supports community projects in New England that aim to reduce environmental risks and improve public health, particularly for vulnerable populations such as children, the elderly, and those in environmental justice areas.

This funding opportunity provides financial support for short-term projects that enhance local governance, infrastructure, education, and public safety in U.S. territories and freely associated states.

This funding opportunity supports collaborations between academic institutions and industry to develop innovative technologies that improve disease diagnosis, treatment, and management, particularly for underserved populations.

This funding opportunity supports organizations working to improve access to information and promote democracy and human rights in North Korea.

As a center of learning, innovation, and leadership that shapes and advances effective correctional practice and public policy, NIC is a vital partner in planning, developing, delivering, and supporting training focused on gender-responsive approaches to working with justice-involved women. NIC training helps correctional staff address the significant challenges they face regarding gender-informed facility operations, policies and procedures, and the development and implementation of evidence-based programs and services that meet womens needs. The growth of knowledge about the types of women who may need to be considered in an agencys response to women and the management strategies that may be most effective for working with this population has also led to advancements in training.This solicitation is for a proposal to enter into a 12-month cooperative agreement to coordinate and deliver two trainings each of Gender-Informed Practices in the Management of Womens Prisons and Justice-Involved Women: Developing an Agencywide Approach, two training programs that address the importance of gender-responsive intervention in a correctional facility.

Agency Name: Army Research Office The Department of Defense (DoD) Multidisciplinary University Research Initiative (MURI), one element of the University Research Initiatives (URI), is sponsored by the DoD research offices. Those offices include the Office of Naval Research (ONR), the Army Research Office (ARO), and the Air Force Office of Scientific Research (AFOSR) (hereafter collectively referred to as "DoD agencies#8220;DoD). This publication constitutes a Funding Opportunity Announcement (FOA) as contemplated in the Department of Defense Grants and Agreements regulations (DoDGARS) 32 CFR 22.315(a). The DoD agencies reserve the right to fund all, some, or none of the proposals received under this FOA. The DoD agencies provide no funding for direct reimbursement of proposal development costs. Technical and budget proposals (or any other material) submitted in response to this FOA will not be returned. It is the policy of the DoD agencies to treat all white papers and proposals submitted under this FOA as sensitive competitive information and to disclose their contents only for the purposes of evaluation. A formal Request for Proposals (RFP), solicitation, and/or additional information regarding this announcement will not be issued. DoD's MURI program addresses high-risk basic research and attempts to understand or achieve something that has never been done before. The program was initiated over 35 years ago and it has regularly produced significant scientific breakthroughs with far reaching consequences to the fields of science, economic growth, and revolutionary new military technologies. Key to the programs success is the close management of the MURI projects by Service Program Officers and their active role in providing research guidance. Awards will take the form of grants. FOR ARO SUBMISSIONS ONLY, awards will take the form of grants and/or cooperative agreements. Any assistance instrument awarded under this announcement will be governed by the award terms and conditions that conform to DoDs implementation of the Office of Management and Budget (OMB) circulars applicable to financial assistance. Terms and conditions will reflect DoD implementation of OMB guidance in 2 CFR Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.

This funding opportunity supports research into how certain diabetes medications may influence cancer risk, encouraging studies that explore the underlying biological mechanisms involved.

Wastewater Based Epidemiology involves analyzing the chemical and biological components present in wastewater to gather information about the health and behavior of a population. Localities have used it to monitor drug consumption patterns in their communities and understand local drug usage trends. It holds promise for monitoring the emergence and geographic distribution of novel substances often referred to as emerging threats. In FY2023, the United States Government funded pilot WBE drug projects that collected wastewater samples in over 70 United States communities representing tens of millions of Americans. The samples were analyzed for parent drugs, such as fentanyl and methamphetamine, and metabolites. Researchers shared results with participating sampled communities, local and state partners, and to a limited extent, the government sponsors.

This program provides funding for organizations in Brazil to preserve important cultural heritage sites, objects, and traditions that are at risk of being lost.

This funding opportunity provides financial support to organizations working to combat domestic violence, dating violence, sexual assault, and stalking in rural communities across the U.S.

This funding opportunity is designed to help organizations acquire and assess commercial satellite imagery to improve flood monitoring and response capabilities in Alaskan communities affected by climate change.

This grant provides funding for innovative research using invasive brain recording and stimulation techniques in humans to improve understanding of the neural circuits involved in mental health disorders.

The purpose of the NINDS Research Program Award (RPA) is to provide longer-term support, and increased freedom and flexibility, to Program Directors (PDs)/Principal Investigators (PIs), to allow them to redirect their time away from the administrative burden of writing and managing multiple grant applications and towards engaging in the lab. This RPA affords investigators at most career stages the opportunity to advance their long-term research goals, rigorously explore exciting research opportunities, and mentor students and postdoctorates, which support and align with the mission of NINDS. RPAs will support the overall research programs of NINDS-funded investigators for up to 8 years, at a level commensurate with a PD/PIs recent NINDS support (Part 2, Section II). This funding stability will provide eligible investigators increased security, allowing them to undertake research projects that require a longer timeframe or to embark upon research that breaks new ground. Research activities outside of the NINDS mission, or traditionally supported by another NIH Institute or Center, will not be considered through this program. Benefits of the RPA include: A more stable funding environment, facilitating the pursuit of longer-term research goals; Flexible funding, enabling investigators to pursue research opportunities as they arise, not tied to specific aims; Reduced time spent writing grant applications and managing multiple grant awards, allowing investigators to spend more time conducting and overseeing research; More time for PDs/PIs to mentor and foster a diverse workforce in their laboratories. NINDS is committed to enhancing the diversity and inclusiveness of the neuroscience workforce. A diverse NIH-supported scientific workforce, including individuals from underrepresented groups, fosters scientific innovation, enhances global competitiveness, contributes to robust learning environments, and improves the quality of the research. See the Notice of NIH

This funding opportunity supports researchers conducting observational studies to improve understanding and treatment of musculoskeletal, rheumatic, and skin diseases, with a focus on patient outcomes and disease progression.